Agilent Technologies is engaged in the life sciences, diagnostics and chemical markets. Co. has three business segments: Life Sciences and Applied Markets, which provides solutions including instruments and software to identify, quantify and analyze the physical and biological properties of substances and products, and to interrogate samples at the molecular and celullar level; Diagnostics and Genomics, which includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses; and Agilent CrossLab, which spans the entire lab with its consumables and services portfolio. We show 34 historical shares outstanding datapoints in our A shares outstanding history coverage, used to compute A market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing A market cap history over the course of time is important for investors
interested in comparing A's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of A versus a peer is one thing; comparing
A market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like A can fluctuate over the course of history.
With this page we aim to empower investors researching A by allowing them to research the A market cap history. |
Video: The Importance of Market Cap
